If you are:
FDB Only When Necessary: INSUFFICIENT HUMAN DATA; CONSIDER MATERNAL TREATMENT BENEFIT
Precaution: HIGH MOLEC WEIGHT,EXCRETION UNLIKELY. POOR ORAL BIOAVAILABILITY
Giving filgrastim Solution to a child under 12:
management or monitoring precaution: Rare reports of development of MDS and AML with underlying congenital neutropenia and chronic use. Rare postmarketing reports of decreased bone density with extended use.